
Nanjing Vishee Medical Technology Co Ltd
SSE:688580

Intrinsic Value
The intrinsic value of one
Nanjing Vishee Medical Technology Co Ltd
stock under the Base Case scenario is
42.04
CNY.
Compared to the current market price of 40.28 CNY,
Nanjing Vishee Medical Technology Co Ltd
is
Undervalued by 4%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Nanjing Vishee Medical Technology Co Ltd
Fundamental Analysis



Revenue & Expenses Breakdown
Nanjing Vishee Medical Technology Co Ltd
Balance Sheet Decomposition
Nanjing Vishee Medical Technology Co Ltd
Current Assets | 1.1B |
Cash & Short-Term Investments | 1B |
Receivables | 43.8m |
Other Current Assets | 66.2m |
Non-Current Assets | 638.4m |
Long-Term Investments | 22m |
PP&E | 390.7m |
Intangibles | 194m |
Other Non-Current Assets | 31.5m |
Free Cash Flow Analysis
Nanjing Vishee Medical Technology Co Ltd
CNY | |
Free Cash Flow | CNY |
Earnings Waterfall
Nanjing Vishee Medical Technology Co Ltd
Revenue
|
422.2m
CNY
|
Cost of Revenue
|
-125.8m
CNY
|
Gross Profit
|
296.4m
CNY
|
Operating Expenses
|
-197m
CNY
|
Operating Income
|
99.5m
CNY
|
Other Expenses
|
13.3m
CNY
|
Net Income
|
112.7m
CNY
|
Profitability Score
Profitability Due Diligence
Nanjing Vishee Medical Technology Co Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Score
Nanjing Vishee Medical Technology Co Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Nanjing Vishee Medical Technology Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Score
Nanjing Vishee Medical Technology Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Nanjing Vishee Medical Technology Co Ltd
According to Wall Street analysts, the average 1-year price target for
Nanjing Vishee Medical Technology Co Ltd
is 37.71 CNY
with a low forecast of 33.33 CNY and a high forecast of 42.99 CNY.
Dividends
Current shareholder yield for Nanjing Vishee Medical Technology Co Ltd is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
Nanjing Vishee Medical Technology Co Ltd
stock under the Base Case scenario is
42.04
CNY.
Compared to the current market price of 40.28 CNY,
Nanjing Vishee Medical Technology Co Ltd
is
Undervalued by 4%.